Clinical trial
Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
NCT00358202 · CPL Associates, Other · Completed
Key facts
| NCT number | NCT00358202 |
|---|---|
| Title | Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia |
| Official title | Phase 4 Study of Once-Daily Intramuscular Cefepime Versus Ceftriaxone for In-Home Treatment of Nursing Home-Acquired Pneumonia |
| Lead sponsor | CPL Associates, Other |
| Collaborators | Elan Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | cefepime, ceftriaxone |
| Enrollment | 69 |
| Start date | Mar 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Jul 31, 2006 |
| Last update posted | Oct 31, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: